Search research articles
Contact Us
Filters
Showing results (171-180 of 273) with videos related to
Page
of 28
Sort By:
Onkologie
|
February 5, 2003
Comparison of 1-hour and 3-hours paclitaxel infusion pharmacokinetics: results from a randomized trial
K Mross, B Häring, N Holländer, et al.
Nanomedicine (London, England)
|
February 3, 2012
Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA
B Leticia Rodriguez, Xinran Li, Kaoru Kiguchi, et al.
Investigative Radiology
|
December 16, 1998
Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent
E C Unger, T P McCreery, R H Sweitzer, et al.
Investigational New Drugs
|
January 17, 2009
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
R Graeser, N Esser, H Unger, et al.
Nanotheranostics
|
November 10, 2025
Novel Phase Shift Microbubbles, MVT-101, Enhance Sonothrombolysis in a Porcine Model of Deep Vein Thrombosis
Joel Lusk, Jinwook Kim, Mark Urtz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 26, 2002
Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells
Z Z Guan, H Miao, J Y Tian, et al.
Radiology
|
December 1, 1992
Cellulose as a gastrointestinal US contrast agent
P J Lund, T A Fritz, E C Unger, et al.
Oncology
|
May 1, 1997
Angiogenesis as a target for tumor treatment
G Gastl, T Hermann, M Steurer, et al.
European Journal of Radiology
|
April 27, 2002
Therapeutic applications of microbubbles
Evan C Unger, Terry Onichi Matsunaga, Thomas McCreery, et al.
Journal of Neuroscience Research
|
December 18, 2001
Reduced expression of neuronal nicotinic acetylcholine receptors during the early stages of damage by oxidative stress in PC12 cells
Z Z Guan, X Zhang, M Mousavi, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 273) with videos related to
Sort By:
Page
of 28
Onkologie
|
February 5, 2003
Comparison of 1-hour and 3-hours paclitaxel infusion pharmacokinetics: results from a randomized trial
K Mross, B Häring, N Holländer, et al.
Nanomedicine (London, England)
|
February 3, 2012
Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA
B Leticia Rodriguez, Xinran Li, Kaoru Kiguchi, et al.
Investigative Radiology
|
December 16, 1998
Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent
E C Unger, T P McCreery, R H Sweitzer, et al.
Investigational New Drugs
|
January 17, 2009
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
R Graeser, N Esser, H Unger, et al.
Nanotheranostics
|
November 10, 2025
Novel Phase Shift Microbubbles, MVT-101, Enhance Sonothrombolysis in a Porcine Model of Deep Vein Thrombosis
Joel Lusk, Jinwook Kim, Mark Urtz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 26, 2002
Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells
Z Z Guan, H Miao, J Y Tian, et al.
Radiology
|
December 1, 1992
Cellulose as a gastrointestinal US contrast agent
P J Lund, T A Fritz, E C Unger, et al.
Oncology
|
May 1, 1997
Angiogenesis as a target for tumor treatment
G Gastl, T Hermann, M Steurer, et al.
European Journal of Radiology
|
April 27, 2002
Therapeutic applications of microbubbles
Evan C Unger, Terry Onichi Matsunaga, Thomas McCreery, et al.
Journal of Neuroscience Research
|
December 18, 2001
Reduced expression of neuronal nicotinic acetylcholine receptors during the early stages of damage by oxidative stress in PC12 cells
Z Z Guan, X Zhang, M Mousavi, et al.
Page
of 28